Pain Relief Patch

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with various conditions, including arthritis, simple backache, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should begin by cleaning and drying the affected area. The patch should then be removed from its protective film and applied directly to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily, with a maximum duration of 7 days. Each patch should be removed from the skin after a maximum application time of 8 hours.

For children under 12 years of age, it is advised to consult a healthcare professional before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse effects.

• Concurrent use with a heating pad is contraindicated, as this may increase the risk of skin burns or other injuries.

• Simultaneous application with other topical analgesics is not recommended, as it may lead to enhanced systemic absorption and increased risk of side effects.

• The product should not be used in individuals with known allergies to any of its ingredients, as this may result in severe allergic reactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a history of allergic reactions to aspirin or salicylates.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately.

Patients should be instructed to discontinue use and contact their healthcare provider under the following circumstances: if a rash, itching, or excessive skin irritation develops; if the condition worsens; if symptoms persist beyond 7 days; or if symptoms resolve and then recur within a few days.

Side Effects

Patients using this product should be aware of several adverse reactions that may occur. Serious adverse reactions include the potential for allergic reactions, particularly in individuals with a known sensitivity to aspirin or salicylates. It is advised that such patients consult a healthcare professional prior to use.

Common adverse reactions reported include skin-related issues. Patients should discontinue use if they experience rash, itching, or excessive skin irritation. Additionally, if the condition being treated worsens, or if symptoms persist for more than 7 days, it is recommended that patients stop using the product. Should symptoms resolve and then recur within a few days, discontinuation is also advised.

This product is intended for external use only, and patients should adhere to these guidelines to ensure their safety and well-being.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they have a history of allergic reactions to aspirin or salicylates, as there may be an increased risk of adverse effects.

Concurrent use of this medication with other topical analgesics is not recommended. The combination may lead to enhanced local irritation or systemic effects, necessitating careful consideration of treatment options. Monitoring for signs of increased irritation or adverse reactions is advised if such combinations are inadvertently used.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patch (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. For adolescents aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily for a maximum of 7 days. The patch should be removed from the skin after an application period of no more than 8 hours.

It is essential to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. Potential risks to the fetus are not clearly defined; therefore, caution is advised when considering the use of this product in pregnant individuals. There are no specific dosage modifications for pregnant patients; healthcare professionals should be consulted for guidance regarding appropriate use in this population.

Lactation

Nursing mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the effects on nursing infants are not well studied; therefore, caution is advised when considering the use of this product during lactation.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of the patient's overall condition.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdosage effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified instances of rash, itching, or excessive skin irritation reported voluntarily or through surveillance programs. In some cases, these conditions have been observed to worsen, with symptoms persisting for more than 7 days. Additionally, there have been reports of symptoms clearing up only to recur within a few days.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed to use the medication only as directed by their healthcare provider. It is important to emphasize the necessity of following the prescribed dosage and administration guidelines to ensure safety and efficacy.

Providers should also caution patients to avoid contact with the eyes, mucous membranes, or any rashes, as this may lead to irritation or adverse reactions. Additionally, patients should be informed not to bandage the area tightly, as this could affect the medication's absorption and increase the risk of side effects.

Storage and Handling

The product is supplied in a clean, dry container designed to protect its contents from excessive moisture. It should be stored in a location that is free from direct sunlight to maintain its integrity. Proper storage conditions are essential to ensure the product remains effective and safe for use.

Additional Clinical Information

The medication is administered topically, with specific guidelines for different age groups. Adults and children aged 12 years and older should apply the medication to the affected area no more than 3 to 4 times daily for a maximum of 7 days, ensuring the patch is removed after no more than 8 hours of application. For children under 12 years of age, consultation with a doctor is advised prior to use.

Clinicians should counsel patients on important safety information. The medication is for external use only, and individuals with a history of allergic reactions to aspirin or salicylates should seek medical advice before use. Patients should avoid contact with the eyes, mucous membranes, or rashes, and should not apply tight bandages over the area. It is crucial to keep the medication out of reach of children, and in the event of ingestion, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Pain Relief Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)